T

The Parkinson's and Movement Disorder Institute | Neurology Department

Research site

(Unclaimed)

Location

9940 Talbert Avenue Suite 100, Fountain Valley, California, United States of America

Site insights

Top conditions

Top treatments

APL-130277

ENT-01

Pimavanserin

Moxifloxacin

PF-06649751

Droxidopa

E2007

Piclozotan

JZP385

Staccato Apomorphine

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 18 total trials

A Study of Lu AF82422 in Participants With Multiple System Atrophy (AMULET)

To find out the effect of Lu AF82422 on disease progression in participants with multiple system atrophy.

Active, not recruiting

Multiple System Atrophy

Drug: Placebo

Drug: Lu AF82422

A Study To Assess the Safety and Efficacy of JZP385 in the Treatment of Adults With Moderate to Severe Essential Tremor (ET)

This is a 12-week, double-blind, placebo-controlled, randomized, parallel-group, multicenter study of the safety and efficacy of JZP385 in the treatm...

Active, not recruiting

Essential Tremor

Drug: JZP385

Other: Placebo

Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy (CYPRESS)

This is a Phase 3, multi-center, randomized withdrawal study to evaluate the efficacy and durability of ampreloxetine in participants with MSA and sy...

Enrolling

MSA - Multiple System Atrophy

Symptomatic Neurogenic Orthostatic Hypotension

Drug: Ampreloxetine

Drug: Placebo